X
skip to main content
Logo

The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.

News & Notices

  • Study by TFRI-funded team underscores importance of accurate diagnosis for rare ovarian and other cancers

    Terry Fox-funded cancer researchers in BC led an international study to develop a new method to improve diagnosis of a rare sub-type of ovarian cancer that has been notoriously difficult to accurately identify. The team has created an algorithm to diagnose and predict the clinical course of granulosa cell cancers of the ovary.

    Read More View all notices

  • Terry Fox researcher leads international conference on ‘devastating’ cancer predisposition syndrome

    Terry Fox-funded researcher Dr. David Malkin, The Hospital for Sick Kids, Toronto, Ontario, was in Columbus, Ohio this week to co-lead the 2016 International Li-Fraumeni Syndrome (LFS) Conference. TFRI funds two projects led by Dr. Malkin, including one focusing solely on LFS.

    Read More View all notices

  • ASM photos now online

    More than 200 Terry Fox researchers attended the 7th Annual Scientific Meeting in Vancouver last week. Under the theme "Understanding Cancer Over Time and Space", the plenary sessions triggered some engaging discussion among attendees and the rapid fire poster talks introduced many trainees to the Terry Fox research family. Photos from the event are now online.

    Read More View all notices

  • TFRI is now smartphone friendly

    Visitors to our site who use mobile or tablet devices will see some welcome updates today as tfri.ca has had a mobile-friendly upgrade. When you visit our website on a mobile device you will find a menu and navigation modified for smaller screens, helping you find the information you need quickly and easily.

    Read More View all notices

Featured Patient Story

Bouncing back from radiation treatment to treat brain tumour

When Valeriya Zolotorgova was 10, her mother began to notice significant changes in the young girl’s hearing and vision. Following visits to doctors, Valeriya was eventually diagnosed with a brain tumour, medulloblastoma, the most common childhood malignant brain tumour with a 30 to 40 per cent mortality rate.

Read the full story
More patient stories

Watch our videos about TFRI-funded research on glioblastoma.

Our Mission & Vision

Terry's vision unites us and inspires our research excellence, innovation and creativity. The Terry Fox Research Institute is a collaboratively oriented, pan-Canadian organization focused on improving cancer research outcomes for the benefit of cancer patients everywhere. We invest in and manage translational research projects across Canada and function as the research arm of The Terry Fox Foundation, managing and overseeing its discovery and training portfolios. We want to ensure that today’s best science becomes tomorrow’s affordable medicine.


Back to Top